About: HER-2/neu Peptide Vaccine     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz:8890 associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • HER-2/neu Peptide Vaccine
equivalentClass
Semantic_Type
  • Pharmacologic Substance
  • Immunologic Factor
Preferred_Name
  • HER-2/neu Peptide Vaccine
NSC_Code
  • 694158
UMLS_CUI
  • C0879250
In_Clinical_Trial_For
  • Stage III or IV HER-2/neu Expressing Cancers and HLA-A2.1 Positive Patients with Recurrent Metastatic Cancer.
PDQ_Open_Trial_Search_ID
  • 42662
PDQ_Closed_Trial_Search_ID
  • 42662
Legacy_Concept_Name
  • HER-2_neu_Peptide_Vaccine
FULL_SYN
  • HER-2-Neu Peptide VaccineSYNCI
  • HER-2/neu Peptide VaccinePTNCI
  • HER-2/neu Helper-Peptide VaccineSYNCI
DEFINITION
  • A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types. (NCI04)NCI
code
  • C2537
is someValuesFrom of
Faceted Search & Find service v1.16.121 as of Mar 31 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3240 as of Mar 31 2025, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 14 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software